In addition, coincident studies indicate that the inhibition of mTOR by AMPK exerts a protective effect by decreasing the development of pulmonary hypertension [77]; thus, under this CIHH condition, the activation of mTOR inhibitory pathways is also a promising cardiovascular therapeutic target [78,79]. Here, MTOR is linked to pulmonary hypertension.